Waubant E - Search Results

1

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Thompson AJ, et al. Among authors: waubant e. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275977 Review.

2

A serial study of new MS lesions and the white matter from which they arise.

Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, Waubant E, Abundo M, Majumdar S, Nelson S, Weiner MW. Goodkin DE, et al. Among authors: waubant e. Neurology. 1998 Dec;51(6):1689-97. doi: 10.1212/wnl.51.6.1689. Neurology. 1998. PMID: 9855524

3

Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability.

Andersson PB, Waubant E, Gee L, Goodkin DE. Andersson PB, et al. Among authors: waubant e. Arch Neurol. 1999 Sep;56(9):1138-42. doi: 10.1001/archneur.56.9.1138. Arch Neurol. 1999. PMID: 10488816

4

A pilot study of MRI activity before and during interferon beta-1a therapy.

Waubant E, Goodkin DE, Sloan R, Andersson PB. Waubant E, et al. Neurology. 1999 Sep 11;53(4):874-6. doi: 10.1212/wnl.53.4.874. Neurology. 1999. PMID: 10489060

5

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.

Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, Andersson PB, Stabler G, Miller K. Waubant E, et al. Neurology. 1999 Oct 22;53(7):1397-401. doi: 10.1212/wnl.53.7.1397. Neurology. 1999. PMID: 10534241

6

A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S. Goodkin DE, et al. Among authors: waubant e. Neurology. 2000 Apr 11;54(7):1414-20. doi: 10.1212/wnl.54.7.1414. Neurology. 2000. PMID: 10751249 Clinical Trial.

7

Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a.

Kita M, Goodkin DE, Bacchetti P, Waubant E, Nelson SJ, Majumdar S. Kita M, et al. Among authors: waubant e. Neurology. 2000 May 9;54(9):1741-5. doi: 10.1212/wnl.54.9.1741. Neurology. 2000. PMID: 10802778

8

Pediatric multiple sclerosis.

Chabas D, Green AJ, Waubant E. Chabas D, et al. Among authors: waubant e. NeuroRx. 2006 Apr;3(2):264-75. doi: 10.1016/j.nurx.2006.01.011. NeuroRx. 2006. PMID: 16554264 Free PMC article. Review.

9

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A. Banwell B, et al. Among authors: waubant e. Lancet Neurol. 2007 Sep;6(9):773-81. doi: 10.1016/S1474-4422(07)70196-5. Lancet Neurol. 2007. PMID: 17689148

10

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH. Bar-Or A, et al. Among authors: waubant e. Ann Neurol. 2008 Mar;63(3):395-400. doi: 10.1002/ana.21363. Ann Neurol. 2008. PMID: 18383069 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page